Rothenberg S S, Schroter G P, Karrer F M, Lilly J R
Department of Surgery, University of Colorado School of Medicine, Denver 80262.
J Pediatr Surg. 1989 Aug;24(8):729-32. doi: 10.1016/s0022-3468(89)80525-1.
One hundred seventy-nine episodes of cholangitis in 28 consecutive patients having a Kasai operation for biliary atresia during the past 3 1/2 years were analyzed. The diagnosis was made primarily on the basis of unexplained fever (greater than 38.0 degrees C). An increase in serum bilirubin or a decrease in bile volume and in bile bilirubin concentration were often confirmatory, but other laboratory data including serum hepatic enzymes and blood and bile culture data were of little or inconsistent value. All patients were treated with systemic antibiotics. The best results were obtained with third-generation cephalosporins or imipenemcilastatin with the addition of aminoglycosides in recalcitrant cases. Antibiotic therapy was modified if defervescence did not occur within the first 24 hours. Cholangitis refractory to antibiotics was aggressively treated with pulse steroid therapy, and in some cases, operative intervention, both with good clinical success (60% and 73%, respectively).
对过去3年半中连续28例因胆道闭锁接受肝门空肠吻合术患者发生的179次胆管炎发作进行了分析。诊断主要基于不明原因发热(体温高于38.0℃)。血清胆红素升高、胆汁量减少以及胆汁胆红素浓度降低常为确诊依据,但包括血清肝酶以及血液和胆汁培养数据在内的其他实验室数据价值不大或不一致。所有患者均接受全身抗生素治疗。使用第三代头孢菌素或亚胺培南西司他丁并在难治性病例中加用氨基糖苷类药物可取得最佳疗效。如果在最初24小时内未退热,则调整抗生素治疗。对抗生素难治的胆管炎采用冲击性类固醇治疗,在某些情况下采用手术干预,临床成功率均较高(分别为60%和73%)。